InsiderTrades

Form 4 for IRMD IRADIMED CORP

Accepted 2026-04-01 15:35:20 ET · period of report 2026-03-30 · accession 0001613801-26-000020 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MTI 2026-04-01 15:35 2026-03-30 IRMD Susi Roger E. CEO, Pres, COB, Dir, 10% S - Sale $95.02 -7,500 2.23M -0.3% -$712.6K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-03-30 S D 5,848 $94.81 2,226,652 I By Phillip Susi 2008 Dynasty Trust — — (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. (F2) This transaction was executed in multiple trades at prices ranging from $94.36 to $95.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
2 Common Common Stock 2026-03-30 S D 1,497 $95.66 2,225,155 I By Phillip Susi 2008 Dynasty Trust — — (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. (F3) This transaction was executed in multiple trades at prices ranging from $95.40 to $96.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3 Common Common Stock 2026-03-30 S D 155 $96.53 2,225,000 I By Phillip Susi 2008 Dynasty Trust — — (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. (F4) This transaction was executed in multiple trades at prices ranging from $96.50 to $97.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.